35 results
Low Ankle Sprain: Pathomechanics and Clinical Findings

Grading Ligament Sprains
l: Minimal ligament disruption, mild swelling & tenderness,
Clinical Findings Grading ... ligament substance leading ... ligament substance leading ... sclerosis #LowAnkleSprain ... #orthopedics #Grading
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Rivaroxaban #Edoxaban #Loading ... #DVT #Pharmacology
Lidocaine HCl - sodium channel blocker. Local anesthetic and class 1B antiarrhythmic. Originally developed in 1943
Local anesthetic ... #Pharmacology #Lidocaine ... Systemic #Review #Overview
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
effects of ACEIs, leading ... alpha-blockers, leading ... of clopidogrel, leading ... betablockers, leading ... supplementals #herbal #pharmacology
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
agents used in anesthesia ... of the patient, leading ... anesthesiology #anesthesia
Drugs Interacting with Sulfonylureas

Drugs that may reduce the effects of sulfonylureas, leading to loss of glucose
sulfonylureas, leading ... sulfonylureas, leading ... #Interactions #Pharmacology
Intraoperative Circulatory Embolus - Guidelines for Crises in Anaesthesia
Causes: thrombus, fat, amniotic fluid, air/gas.
Signs: hypotension, tachycardia,
for Crises in Anaesthesia ... air • Volume loading ... for crises in anaesthesia ... Anesthesiology #Anesthesia
COVID-19 review…here is a list of some of the drugs that are currently being used or
announced it is leading ... Pharmacotherapy #Pharmacology
Digoxin Dosing - Pharmacology

Loading: 0.5 mg IV followed by 0.25 mg IV q6h x 2
Maintenance: 0.125
Digoxin Dosing - Pharmacology ... Loading: 0.5 mg ... Digoxin #Dosing #Pharmacology ... #loading #maintenance
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
DOACs thereby leading ... metabolization leading ... Interactions #Table #Pharmacology